ACHN - Achillion Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue-15,00066,122
Cost of Revenue---
Gross Profit-15,00066,122
Operating Expenses
Research Development65,05259,16256,553
Selling General and Administrative24,52420,70324,676
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-89,576-64,865-15,107
Income from Continuing Operations
Total Other Income/Expenses Net4,3903,22710,132
Earnings Before Interest and Taxes-85,186-61,638-4,975
Interest Expense506855
Income Before Tax-85,236-61,706-5,030
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-85,236-61,706-5,030
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-85,236-61,706-5,030
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-85,236-61,706-5,030